{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:11:05Z","timestamp":1789261865475,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several studies have investigated the correlation between the serum anti-M\u00fcllerian hormone (AMH) level and in vitro fertilization (IVF) outcomes in controlled ovarian stimulation cycles; however, studies regarding the correlation of the serum AMH level with IVF outcomes in minimal ovarian stimulation cycles remain limited. In this study, we aimed to analyze the correlation of the serum AMH level with ovarian responsiveness, embryonic outcomes, and cumulative live birth rates in clomiphene citrate (CC)-based minimal ovarian stimulation cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical records of 689 women whose entire ovarian stimulation regimen consisted solely of minimal stimulation cycle IVF using CC alone from November 2017 to October 2019 were retrospectively reviewed. The association between IVF outcomes and the serum AMH level before the initiation of the first fertility treatment was analyzed. Furthermore, the correlation of the serum AMH level with cumulative live birth rates after IVF treatment was assessed. The Cochran-Armitage test, Pearson\u2019s chi-squared test, Spearman rank correlation test, Student\u2019s t-test, one-way analysis of variance, logistic regression analysis, Kaplan-Meier method and Cox proportional hazards model were used to analyze the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The serum AMH level positively correlated with the number of retrieved oocytes, blastocyst formation rate, blastocyst cryopreservation rate, and live birth rate per oocyte retrieval in CC-based minimal ovarian stimulation cycles without any exogenous gonadotropin administration. Furthermore, the cumulative live birth rate and treatment period required for conceiving were strongly associated with the serum AMH level at the initiation of fertility treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A low serum AMH level correlated with low ovarian responsiveness, impaired pre-implantation embryonic development, and decreased cumulative live birth rate in CC-based minimal ovarian stimulation cycles. Therefore, the cycle success rate would be predicted by measuring the serum AMH level in minimal ovarian stimulation with CC alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-020-03446-1","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T05:02:45Z","timestamp":1606453365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-M\u00fcllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Kenji","family":"Ezoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-4532","authenticated-orcid":false,"given":"Keiichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"issue":"2","key":"3446_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77\u201383 Epub 2004\/01\/27.","journal-title":"Mol Hum Reprod"},{"issue":"8","key":"3446_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/molehr\/gat024","volume":"19","author":"JV Jeppesen","year":"2013","unstructured":"Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519\u201327 Epub 2013\/04\/09.","journal-title":"Mol Hum Reprod"},{"key":"3446_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jncimonographs\/lgi026","volume":"34","author":"AP Themmen","year":"2005","unstructured":"Themmen AP. Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr. 2005;34:18\u201321 Epub 2005\/03\/24.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1\u20132","key":"3446_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","volume":"234","author":"JA Visser","year":"2005","unstructured":"Visser JA, Themmen AP. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005;234(1\u20132):81\u20136 Epub 2005\/04\/20.","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"3446_CR5","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A La Marca","year":"2006","unstructured":"La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21(12):3103\u20137 Epub 2006\/08\/23.","journal-title":"Hum Reprod"},{"issue":"10","key":"3446_CR6","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1210\/jc.2006-0331","volume":"91","author":"WJ Hehenkamp","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91(10):4057\u201363 Epub 2006\/06\/29.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3446_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/dem101","volume":"22","author":"S Tsepelidis","year":"2007","unstructured":"Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22(7):1837\u201340 Epub 2007\/05\/09.","journal-title":"Hum Reprod"},{"issue":"2","key":"3446_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","volume":"90","author":"I Streuli","year":"2008","unstructured":"Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90(2):395\u2013400 Epub 2007\/10\/09.","journal-title":"Fertil Steril"},{"issue":"2","key":"3446_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330 Epub 2009\/10\/02.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"3446_CR10","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1210\/jc.2008-0567","volume":"93","author":"MR Sowers","year":"2008","unstructured":"Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93(9):3478\u201383 Epub 2008\/07\/03.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3446_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1210\/jc.2007-2093","volume":"93","author":"J van Disseldorp","year":"2008","unstructured":"van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab. 2008;93(6):2129\u201334 Epub 2008\/03\/13.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3446_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10815-009-9332-8","volume":"26","author":"CH Wu","year":"2009","unstructured":"Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. Serum anti-Mullerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet. 2009;26(7):383\u20139 Epub 2009\/09\/22.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"3446_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77(3):468\u201371 Epub 2002\/03\/02.","journal-title":"Fertil Steril"},{"issue":"1","key":"3446_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humrep\/dei270","volume":"21","author":"T Silberstein","year":"2006","unstructured":"Silberstein T, MacLaughlin DT, Shai I, Trimarchi JR, Lambert-Messerlian G, Seifer DB, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21(1):159\u201363 Epub 2005\/08\/27.","journal-title":"Hum Reprod"},{"issue":"9","key":"3446_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. Hum Reprod. 2007;22(9):2414\u201321 Epub 2007\/07\/20.","journal-title":"Hum Reprod"},{"issue":"4","key":"3446_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","volume":"89","author":"DM Wunder","year":"2008","unstructured":"Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhauser MH. Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril. 2008;89(4):927\u201333 Epub 2007\/07\/03.","journal-title":"Fertil Steril"},{"issue":"6","key":"3446_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"JC Arce","year":"2013","unstructured":"Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99(6):1644\u201353 Epub 2013\/02\/12.","journal-title":"Fertil Steril"},{"issue":"3","key":"3446_CR18","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2012-3676","volume":"98","author":"T Brodin","year":"2013","unstructured":"Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98(3):1107\u201314 Epub 2013\/02\/15.","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"3446_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2017.14588","volume":"318","author":"AZ Steiner","year":"2017","unstructured":"Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, et al. Association between biomarkers of Ovarian reserve and infertility among older women of reproductive age. Jama. 2017;318(14):1367\u201376 Epub 2017\/10\/20.","journal-title":"Jama."},{"key":"3446_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejogrb.2016.07.498","volume":"204","author":"D Song","year":"2016","unstructured":"Song D, Shi Y, Zhong Y, Meng Q, Hou S, Li H. Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\\ICSI procedures: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016;204:36\u201343 Epub 2016\/08\/16.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"3446_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","volume":"3","author":"E Kousta","year":"1997","unstructured":"Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 1997;3(4):359\u201365 Epub 1997\/07\/01.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"3446_CR22","doi-asserted-by":"publisher","first-page":"96 e1","DOI":"10.1016\/j.ajog.2015.08.009","volume":"214","author":"JJ Zhang","year":"2016","unstructured":"Zhang JJ, Merhi Z, Yang M, Bodri D, Chavez-Badiola A, Repping S, et al. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial. Am J Obstet Gynecol. 2016;214(1):96 e1\u20138 Epub 2015\/08\/12.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"3446_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.rbmo.2014.01.002","volume":"28","author":"D Bodri","year":"2014","unstructured":"Bodri D, Kawachiya S, De Brucker M, Tournaye H, Kondo M, Kato R, et al. Cumulative success rates following mild IVF in unselected infertile patients: a 3-year, single-Centre cohort study. Reprod BioMed Online. 2014;28(5):572\u201381 Epub 2014\/03\/19.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"3446_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/humrep\/den442","volume":"24","author":"E Flisser","year":"2009","unstructured":"Flisser E, Copperman AB. Why do couples drop-out from IVF treatment? Hum Reprod. 2009;24(3):758\u20139 author reply 9. Epub 2008\/12\/17.","journal-title":"Hum Reprod"},{"issue":"1","key":"3446_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/humupd\/dmn053","volume":"15","author":"MF Verberg","year":"2009","unstructured":"Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, et al. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update. 2009;15(1):5\u201312 Epub 2008\/12\/19.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"3446_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/humupd\/dmn056","volume":"15","author":"MF Verberg","year":"2009","unstructured":"Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, et al. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009;15(1):13\u201329 Epub 2008\/12\/19.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"3446_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00404-012-2672-0","volume":"287","author":"JB Figueiredo","year":"2013","unstructured":"Figueiredo JB, Nastri CO, Vieira AD, Martins WP. Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis. Arch Gynecol Obstet. 2013;287(4):779\u201390 Epub 2012\/12\/20.","journal-title":"Arch Gynecol Obstet"},{"key":"3446_CR28","first-page":"CD008528","volume":"11","author":"A Gibreel","year":"2012","unstructured":"Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane Database Syst Rev. 2012;11:CD008528 Epub 2012\/11\/16.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3446_CR29","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"T Ovarian Stimulation","year":"2020","unstructured":"Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI (dagger). Hum Reprod Open. 2020;2020(2):hoaa009 Epub 2020\/05\/13.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"3446_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.rbmo.2020.02.017","volume":"41","author":"K Ezoe","year":"2020","unstructured":"Ezoe K, Hickman C, Miki T, Okimura T, Uchiyama K, Yabuuchi A, et al. Cytoplasmic halo characteristics during fertilization and their implications for human preimplantation embryo development and pregnancy outcome. Reprod BioMed Online. 2020;41(2):191\u2013202 Epub 2020\/06\/17.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"3446_CR31","doi-asserted-by":"publisher","first-page":"hoy006","DOI":"10.1093\/hropen\/hoy006","volume":"2018","author":"K Kato","year":"2018","unstructured":"Kato K, Ezoe K, Yabuuchi A, Fukuda J, Kuroda T, Ueno S, et al. Comparison of pregnancy outcomes following fresh and electively frozen single blastocyst transfer in natural cycle and clomiphene-stimulated IVF cycles. Hum Reprod Open. 2018;2018(3):hoy006 Epub 2019\/03\/22.","journal-title":"Hum Reprod Open"},{"issue":"5","key":"3446_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.rbmo.2018.12.014","volume":"38","author":"K Ezoe","year":"2019","unstructured":"Ezoe K, Ohata K, Morita H, Ueno S, Miki T, Okimura T, et al. Prolonged blastomere movement induced by the delay of pronuclear fading and first cell division adversely affects pregnancy outcomes after fresh embryo transfer on day 2: a time-lapse study. Reprod BioMed Online. 2019;38(5):659\u201368 Epub 2019\/03\/12.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"3446_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12958-019-0488-5","volume":"17","author":"K Ohata","year":"2019","unstructured":"Ohata K, Ezoe K, Miki T, Morita H, Tsuchiya R, Kaneko S, et al. Blastomere movement post first cell division correlates with embryonic compaction and subsequent blastocyst formation. Reprod Biol Endocrinol. 2019;17(1):44 Epub 2019\/05\/17.","journal-title":"Reprod Biol Endocrinol"},{"key":"3446_CR34","volume-title":"Abnormal morphology of human oocytes and conceptus. Atlas of the human oocyte and early conceptus","author":"LL Veeck","year":"1996","unstructured":"Veeck LL. In: Veeck LL, editor. Abnormal morphology of human oocytes and conceptus. Atlas of the human oocyte and early conceptus. 2nd ed. Baltimore: Williams & Wilkins; 1996.","edition":"2"},{"key":"3446_CR35","unstructured":"Gardner D, Schoolcraft W. In vitro culture of human blastocysts. Jansen R, editor. Carnforth: Parthenon Publishing; 1999."},{"issue":"6","key":"3446_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.rbmo.2015.02.004","volume":"30","author":"C Mori","year":"2015","unstructured":"Mori C, Yabuuchi A, Ezoe K, Murata N, Takayama Y, Okimura T, et al. Hydroxypropyl cellulose as an option for supplementation of cryoprotectant solutions for embryo vitrification in human assisted reproductive technologies. Reprod BioMed Online. 2015;30(6):613\u201321 Epub 2015\/04\/22.","journal-title":"Reprod BioMed Online"},{"key":"3446_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7827-10-35","volume":"10","author":"K Kato","year":"2012","unstructured":"Kato K, Takehara Y, Segawa T, Kawachiya S, Okuno T, Kobayashi T, et al. Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-Centre, Japanese cohort. Reprod Biol Endocrinol. 2012;10:35 Epub 2012\/05\/01.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"3446_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijgo.2015.08.001","volume":"132","author":"J Fukuda","year":"2016","unstructured":"Fukuda J, Abe T, Okuno T, Kobayashi T, Kato K. Administering human chorionic gonadotropin injections for triggering follicle maturation could impact fertility during the subsequent menstrual cycle. Int J Gynaecol Obstet. 2016;132(3):309\u201313 Epub 2015\/12\/09.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"3446_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/rmb2.12310","volume":"19","author":"S Karakida","year":"2020","unstructured":"Karakida S, Ezoe K, Fukuda J, Yabuuchi A, Kobayashi T, Kato K. Effects of gonadotropin administration on clinical outcomes in clomiphene citrate-based minimal stimulation cycle IVF. Reprod Med Biol. 2020;19(2):128\u201334 Epub 2020\/04\/11.","journal-title":"Reprod Med Biol"},{"issue":"5","key":"3446_CR40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","volume":"82","author":"A Hazout","year":"2004","unstructured":"Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82(5):1323\u20139 Epub 2004\/11\/10.","journal-title":"Fertil Steril"},{"issue":"8","key":"3446_CR41","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/humrep\/del127","volume":"21","author":"T Ebner","year":"2006","unstructured":"Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21(8):2022\u20136 Epub 2006\/05\/09.","journal-title":"Hum Reprod"},{"issue":"12","key":"3446_CR42","first-page":"604","volume":"12","author":"S Cupisti","year":"2007","unstructured":"Cupisti S, Dittrich R, Mueller A, Strick R, Stiegler E, Binder H, et al. Correlations between anti-mullerian hormone, inhibin B, and activin a in follicular fluid in IVF\/ICSI patients for assessing the maturation and developmental potential of oocytes. Eur J Med Res. 2007;12(12):604\u20138 Epub 2007\/11\/21.","journal-title":"Eur J Med Res"},{"issue":"5","key":"3446_CR43","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2006-1053","volume":"92","author":"R Fanchin","year":"2007","unstructured":"Fanchin R, Mendez Lozano DH, Frydman N, Gougeon A, di Clemente N, Frydman R, et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab. 2007;92(5):1796\u2013802 Epub 2007\/03\/01.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3446_CR44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-Mullerian hormone as a predictor of IVF outcome. Reprod BioMed Online. 2007;14(5):602\u201310 Epub 2007\/05\/19.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"3446_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-018-0430-z","volume":"11","author":"S Wang","year":"2018","unstructured":"Wang S, Zhang Y, Mensah V, Huber WJ 3rd, Huang YT, Alvero R. Discordant anti-mullerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth? J Ovarian Res. 2018;11(1):60 Epub 2018\/07\/18.","journal-title":"J Ovarian Res"},{"issue":"8","key":"3446_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.29252\/ijrm.14.8.501","volume":"14","author":"E Shahrokh Tehraninezhad","year":"2016","unstructured":"Shahrokh Tehraninezhad E, Mehrabi F, Taati R, Kalantar V, Aziminekoo E, Tarafdari A. Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF\/ICSI patients. Int J Reprod Biomed (Yazd). 2016;14(8):501\u20136 Epub 2016\/09\/30.","journal-title":"Int J Reprod Biomed (Yazd)"},{"issue":"1","key":"3446_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.rbmo.2013.09.017","volume":"28","author":"K Lukaszuk","year":"2014","unstructured":"Lukaszuk K, Kunicki M, Liss J, Bednarowska A, Jakiel G. Probability of live birth in women with extremely low anti-Mullerian hormone concentrations. Reprod BioMed Online. 2014;28(1):64\u20139 Epub 2013\/11\/26.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"3446_CR48","first-page":"24","volume":"10","author":"M Goswami","year":"2017","unstructured":"Goswami M, Nikolaou D. Is AMH level, independent of age, a predictor of live birth in IVF? J Hum Reprod Sci. 2017;10(1):24\u201330 Epub 2017\/05\/10.","journal-title":"J Hum Reprod Sci"},{"issue":"10","key":"3446_CR49","doi-asserted-by":"publisher","first-page":"e108493","DOI":"10.1371\/journal.pone.0108493","volume":"9","author":"HW Li","year":"2014","unstructured":"Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. PLoS One. 2014;9(10):e108493 Epub 2014\/10\/15.","journal-title":"PLoS One"},{"issue":"9","key":"3446_CR50","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/humrep\/dey263","volume":"33","author":"JA Leijdekkers","year":"2018","unstructured":"Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, McLernon DJ, Bhattacharya S, et al. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study. Hum Reprod. 2018;33(9):1684\u201395 Epub 2018\/08\/08.","journal-title":"Hum Reprod"},{"issue":"4","key":"3446_CR51","doi-asserted-by":"publisher","first-page":"e61095","DOI":"10.1371\/journal.pone.0061095","volume":"8","author":"HW Li","year":"2013","unstructured":"Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLoS One. 2013;8(4):e61095 Epub 2013\/05\/03.","journal-title":"PLoS One"},{"issue":"4","key":"3446_CR52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","volume":"104","author":"O Hamdine","year":"2015","unstructured":"Hamdine O, Eijkemans MJC, Lentjes EGW, Torrance HL, Macklon NS, Fauser B, et al. Antimullerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril. 2015;104(4):891\u20138 e2. Epub 2015\/07\/22.","journal-title":"Fertil Steril"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03446-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-03446-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03446-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T05:12:10Z","timestamp":1606453930000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03446-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3446"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03446-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective cohort study was approved by the Institutional Review Board of Kato Ladies Clinic (approval number: 17\u201319). Written informed consent for the analysis of de-identified data was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"740"}}